Clinical trial

Study to Assess the Safety and Effectiveness of NMRA-335140-501

NCT06029439

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention NMRA-335140 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study to Assess the Safety and Effectiveness of NMRA-335140-501

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2023-11-10

PhasePHASE3

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

NMRA-335140DRUG

Sponsors & collaborators

Neumora Therapeutics, Inc.lead sponsor

Mapped research locations

MiamiFlorida, United States8 AtlantaGeorgia, United States4 BerlinGermany4 OrlandoFlorida, United States4 New YorkNew York, United States3 HoustonTexas, United States3 TampaFlorida, United States3 BostonMassachusetts, United States2 AustinTexas, United States2 Little RockArkansas, United States2 Long BeachCalifornia, United States2 OrangeCalifornia, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06029439 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.